Investors

Who we are

RenalytixAI is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs.  Our goal is to lower healthcare costs and improve patient quality of life by transforming the paradigm for kidney disease risk assessment and clinical management through our KidneyIntelX platform.

btn Profile

Company Metrics
Leading the market year after year

  •    
    Addressing one of the largest and costliest unmet needs in healthcare
  •    
    Listed on AIM (November, 2018) and Nasdaq (July, 2020)
  •    
    Lead solution, KidneyIntelX, approved by NY State Department of Health (June, 2020)

Stock Performance

select Stock

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Data Provided by Refinitiv. Minimum 15 minutes delayed.